Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
In this Executive Master, you will gain a theoretical and conceptual understanding of health economics, outcomes research and management, and the relevant social science principles of the cardiovascular disease fields. These added skills will empower you to shape the future of cardiovascular medicine.
We are now accepting applications for the academic years 2020/2021
Programme start date: December 2020
The Executive MSc Health Economics, Outcomes and Management in Cardiovascular Sciences prepares students to explore new advisory, management and leadership roles within the healthcare field. This programme will expand your employment opportunities in related sectors including health care provider management roles, pharmaceutical and medical devices industries, consultancies, government and non-governmental organisations. Upon graduation, you can expect to take on more responsibilities or shift your career focus towards the cardiovascular science field.
The programme consists of eight modules over two academic years. On-site modules are taught two weeks in December and two weeks in June, each year, at the London School of Economics (LSE) in London. In addition to time spent in the classroom, you will also be expected to complete coursework from a distance.
The course language is English.
Graded assignments may vary from take-home exams, essays, reports to the group and individual projects.
Find more information about the programme on LSE dedicated page: lse.ac.uk/Cardio-exec-MSc
This programme targets medical doctors, healthcare professionals, and scientists working on cardiovascular diseases. It has been designed to meet the needs of future cardiology leaders who seek formal qualifications but cannot participate in a traditional full-time MSc programme.
Some of the mandatory courses will focus on cardiovascular disease; therefore, experience in cardiovascular science either as a practising cardiologist or as a health economist is desirable. Outstanding candidates with different backgrounds in health care are strongly encouraged to apply.
Students with previous training in health economics or policy can benefit from our more advanced course options.
Tuition fees 2020/21 for Executive MSc Health Economics, Outcomes and Management in Cardiovascular Sciences: £14,443 per annum for a total of GBP 28,886. The same fees apply for UK/EU and overseas students.
Tuition fees include:
The ESC supports the education of future leaders in cardiovascular medicine by offering 15 scholarships.
The amount of each scholarship is: £15,500/programme.
Scholarship application extended deadline: 05 March 2020
Please be aware that gathering and submitting all the documents required for your application will take time. We strongly encourage you to not delay your application and be mindful of the scholarship application deadline.
The Scholarship Selection Committee is looking for excellent references, a focused personal statement and relevant work experience. The result of the scholarship selection committee will be communicated to all scholarship applicants in April 2020.
Please note that applications completed after 05 March 2020 may still be eligible for admissions consideration, but will not be considered for the ESC scholarship.
Information on the payment scheme
The programme operates on rolling admissions. The sooner the complete application is submitted, the greater your chances are to join the programme. The approximate number of participants is 35 per intake.
Before starting your application please make sure you've read all relevant information on LSE website: lse.ac.uk/Cardio-exec-MSc
To apply for a scholarship, fill out both before 05 March 2020:
If you would like more information on the programme or the application procedure, please contact us.
This executive master is organized thanks to the collaboration between European Heart Academy of ESC and London School of Economics (LSE).
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.